Video

Q&A With Stacey Cofield, PhD, From University of Alabama at Birmingham: NARCOMS Survey Takes Closer Look at Marijuana Use Among Patients with Multiple Sclerosis

Author(s):

The issue of marijuana use is complicated for many reasons. One of the biggest, according to a recent survey is the willingness of patients and healthcare providers alike to even discuss the topic.

The issue of marijuana use is complicated for many reasons. One of the biggest, according to a recent survey is the willingness of patients and healthcare providers alike to even discuss the topic.

Stacey Cofield, PhD, from the University of Alabama at Birmingham discussed the results of a confidential survey during the 2015 Annual Meeting of the Consortium of Multiple Sclerosis Centers in Indianapolis Cofield said the confidential nature of the survey allowed patients to more freely express their opinions on the topic. She said the results of the survey showed that more discussion was needed in order to better understand the potential benefits of marijuana in patient care.

Related Videos
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
Lauren Collen, MD: Some Fragrances May be More Prevalent in Exposomes of Children with Crohn’s Disease
Impact of Long Hospital Stays on Pediatric Gastroparesis Management with Christian Sadaka, MD
Christian Sadaka, MD: Significant Increase in Pediatric Gastroparesis Hospital Admissions After COVID-19
Akif Shameem, MD: Generalized Anxiety Disorder Linked to Longer Hospitals in Children with IBD
Implications of Findings on Patient-Reported Outcomes for Roflumilast Foam, with Melinda Gooderham, MD
New Findings on Psoriasis Outcomes for Roflumilast Foam 0.3%, with Melinda Gooderham, MD
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.